NAVIGATING DIGITAL HEALTH - Members of the public co-create educational guide demystifying the role of artificial intelligence and data science in healthcare.
A new study focused on decoding the genetic chaos found in cancer cells is on the cover of the June issue of the scientific journal Nature.This work reveals novel biomarkers with the potential
Blood test picks out prostate cancer drug resistance 04
Blood test picks out prostate cancer drug resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
The new research paves the way for information from a blood test to inform prostate cancer treatment in future, with only those patients whose cancers are free of resistance mutations taking the drug, abiraterone.
The study is also a proof of principle that tests for cancer DNA in the bloodstream can be used to detect drug resistance mutations – allowing patients who will not benefit from one drug to be given an alternative treatment instead.